恩威医药

301331 SZSE 证监会行业分类 C27医药制造业

Key Metrics

Market Cap

2.7B ($393.9M)

P/E Ratio

N/A

P/B Ratio

N/A

Revenue

812.0M

Net Income

37.5M

Gross Margin

N/A

Op. Margin

6.1%

Net Margin

4.6%

ROE

3.5%

ROA

2.5%

D/E

0.42

Dividend Yield

N/A

EPS

0.37

Current Ratio

4.00

Price History

Company Info

Industry	C27医药制造业
Market Segment	ChiNext
Currency	CNY
Fiscal Year	2024

Business Overview

Enwei Pharmaceutical Co., Ltd. engages in the development and sale of Chinese medicines in China. The company offers drugs in the areas of gynecology, pediatrics, and respiratory system fields. The company was founded in 2005 and is based in Chengdu, China.

Full Financials Advanced Charts Filings

Peers

工商银行

601398

2.7T

P/E: 7.6

建设银行

601939

2.5T

P/E: 7.2

农业银行

601288

2.4T

P/E: 8.7

中国海油

600938

2.0T

P/E: 16.2

宁德时代

300750

1.9T

P/E: 25.6

贵州茅台

600519

1.8T

P/E: 20.1

中国银行

601988

1.8T

P/E: 7.3

中国人寿

601628

1.2T

P/E: 6.9

Financial Statements

Loading financials...

Open Advanced Charts

Full charting with technical indicators, candlestick, and more.

About 恩威医药

Ticker	301331
Exchange	SZSE
Sector	证监会行业分类
Industry	C27医药制造业